Oracle — The information technology stock climbed 13.3% on the back of strong per-share earnings. Oracle posted adjusted earnings per share of $1.41, topping the $1.38 consensus estimate of analysts polled by LSEG.
On Holding — Shares plunged more than 14% after the shoemaker posted quarterly results that disappointed investors. In its fourth quarter, On Holding reported a loss of CHF0.05), below the expectation CHF0.10 earnings per share, according to the StreetAccount consensus estimate. Revenue of CHF447.1 million missed the CHF450.9 million consensus estimate.
Kohl’s — Shares added 2.2% after the retailer reporting an earnings and revenue beat for the fourth quarter. Earnings per share came in at $1.67, besting the $1.28 consensus estimate, per LSEG. Revenue was $5.71 billion, versus the $5.7 billion expected. The company also announced it would add Babies R Us to around 200 stores this fall.
Asana — The work management platform slipped 2.3% after offering weak full-year revenue guidance. Asana said to expect between $716 million and $722 million, missing the forecast of $725 million from analysts surveyed by LSEG. That pulled attention away from a better-than-anticipated earnings report for the fourth quarter.
Coinbase — Shares added 2.1% after Raymond James said it was less pessimistic on the crypto trading platform. The firm upgraded the stock to market perform from underperform, citing the impact from exchange-traded funds on inflows.
Southwest Airlines — The airline stock slid 7% after Southwest Airlines said it was “reevaluating all prior full year 2024 guidance, including the expectation for capital spending” due to aircraft delivery delays from Boeing. The airline expects its unit revenue will be flat to up no more than 2% compared to a year earlier, lower than its January estimate calling for rise of as much as 4.5%. Southwest also stated that first-quarter leisure bookings were weaker than expected.
Bitdeer Technologies — The crypto stock popped 4.6% following B. Riley’s initiation at a buy rating. The firm said Bitdeer is well-positioned due to its diverse business model and access to low-cost power.
Ventyx — The biopharmaceutical stock rose 7.1% as Wall Street found reasons to like its latest clinical update. Wells Fargo upgraded the stock to overweight, while raising its price target for shares to $16. Meanwhile, Oppenheimer upgraded its rating to outperform and upped its target price to $12 per share.
Microstrategy — The bitcoin developer jumped 6.2% on the back of bullish commentary from Wall Street analysts. Canaccord Genuity, which has a buy rating, said the stock is not “resting on its laurels” as bitcoin rallies to all-time highs and yanked up its price target to $1,810. TD Cowen also raised its price target to $1,560 while keeping its outperform rating, noting its quick increase to incremental bitcoin holdings.
